Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Virtual Caregiver Coach for You (ViCCY)

Study ID: NCT07220798
Start Date: 2026-06-15
End Date: 2029-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

314

Intervention / Treatment

ViCCY

Sponsor

Visiting Nurse Service of New York

Source: clinicaltrials.gov

Share:
Add to list

Synergistic Minimally Invasive Surgery and Deferoxamine in ICH

Study ID: NCT07162363
Start Date: 2026-03-01
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

240

Intervention / Treatment

Minimally Invasive surgery (MIS)

Deferoxamine

Standard Medical Care (SMD)

Sponsor

University of Illinois at Chicago

Source: clinicaltrials.gov

Share:
Add to list

Pivotal Study of N-acetyl-L-leucine for CACNA1A

Study ID: NCT07221292
Start Date: 2026-09-01
End Date: 2028-11-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

60

Intervention / Treatment

N-Acetyl-L-Leucine

Placebo

Sponsor

IntraBio Inc

Source: clinicaltrials.gov

Share:
Add to list

Enhancing Wound Perfusion in High-Risk Lower Extremity Orthopaedic Surgery: A Study on Nitropaste Using Intraoperative SPY Imaging.

Study ID: NCT07004764
Start Date: 2026-03
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

Nitroglycerin Ointment 2%

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Correlates and Control of Blood Pressure Variability

Study ID: NCT06012487
Start Date: 2026-05-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

Low BPV Regimen

Sponsor

Cedars-Sinai Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Study ID: NCT07258511
Start Date: 2026-02-20
End Date: 2031-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

JNJ-79635322

Teclistamab

Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)

Study ID: NCT07269938
Start Date: 2026-04
End Date: 2029-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Zirconium Zr 89 labelled rituximab

Sponsor

University of Edinburgh

Source: clinicaltrials.gov

Share:
Add to list

Psoas Muscle Release in Non-specific Mechanical Low Back Pain

Study ID: NCT06994364
Start Date: 2026-04
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Trigger point release

Simulation of the intestinal listening technique.

Sponsor

Porto Higher School of Health Technology

Source: clinicaltrials.gov

Share:
Add to list

Connecting People With Cancer to Employment Support

Study ID: NCT07027449
Start Date: 2028-01
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Screening and Referral Workflow

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients

Study ID: NCT07366658
Start Date: 2026-02-20
End Date: 2027-01-20
Study Type

Interventional

Study Phase

Phase1

No. of Participants

9

Intervention / Treatment

Biological/Vaccine: NK Cell Therapy Product Derived from Induced Pluripotent Stem Cells (iPSCs) Engineered with Anti-DLL3 CAR Construct, Followed by Differentiation and Expansion

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list